MarketPeel
Insider Trading Intelligence
FG

Fred Grossman

COYA
CHIEF MEDICAL OFFICER · COYA THERAPEUTICS, INC. · CIK 0001985154
FILING MIX · LIFETIME100%/0%
BUYS
7
SELLS
0
TOTAL VALUE
$20.0K
COMPANIES
1
ACTIVE SINCE
Jul 2023
HOLDINGS NOW
140,041
AVG SELL PX
TRADE KIND
SHOWING 7 / 7
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizons · 1 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Fred Grossman, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+0.00%-17.19%-1.77%-15.42%-15.42%
14d1+0.00%-11.32%-0.21%-11.12%-11.12%
30d1+0.00%-15.28%+1.45%-16.73%-16.73%
60d1+0.00%-21.28%-2.73%-18.56%-18.56%
90d1+0.00%-6.14%+1.36%-7.50%-7.50%
180d1+0.00%-17.46%-5.15%-12.31%-12.31%
1y1+0.00%-18.01%+14.80%-32.80%-32.80%
2y1(1 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
COYA · 140,041 shares · as of Jan 22, 2026
035,14170,281105,422140,562202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 7 buys / 0 sellsCOVERAGE · 11 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
COYA
COYA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
140,041140,041Jan 22, 2026Jan 26, 2026View →
COYA
COYA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
140,562140,562Jan 9, 2025Jan 13, 2025View →
COYA
COYA THERAPEUTICS, INC.
PURCHASE
Chief Medical Officer
2,710$7.37$20.0K2,710Nov 11, 2024Nov 12, 2024View →
COYA
COYA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
70,59670,596Jun 3, 2024Jun 5, 2024View →
COYA
COYA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
74,06974,069Jan 31, 2024Feb 2, 2023View →
COYA
COYA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
81,81981,819Jan 31, 2024Feb 2, 2023View →
COYA
COYA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
74,06974,069Jul 17, 2023Jul 19, 2023View →
Other insiders · COYA
Loading peer insiders…
About this filer
CIK 0001985154
ROLE
Chief Medical Officer
PRIMARY
COYA
COMPANIES
1
ACTIVE SINCE
Jul 2023
MARKETPEEL · /INSIDER/0001985154DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback